Mohan Raju — SEC Form 4 filings
SEC reporting owner CIK 1878125. 9 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-29 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 500,000 shares, $959,889 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 51,657 shares, $388,760 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 261,752 shares @ $2.01 ($524,944) in Ventyx Biosciences, Inc., filed 2024-11-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) | CEO AND PRESIDENT, Director | 9 | 2 legs · 500,000 sh · $959,889 | 2 legs · 51,657 sh · $388,760 | 21 |
Form 4 filings — Mohan Raju
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 2,372,863 · Disposition to issuer (D): 23,688 (derivative) · Disposition to issuer (D): 700,000 (derivative) · Disposition to issuer (D): 155,000 (derivative) · Disposition to issuer (D): 473,750 (derivative) · Disposition to issuer (D): 370,000 (derivative) · +4 more | EDGAR |
| 2025-12-19 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 116,668 @ $0 · Sale (S): 47,345 @ $7.72 · Option exercise (M): 116,668 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 11,844 @ $0 · Option exercise (M): 11,844 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 116,668 @ $0 · Option exercise (M): 116,668 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Ventyx Biosciences, Inc. (VTYX) | Purchase (P): 238,248 @ $1.83 · Purchase (P): 261,752 @ $2.01 | EDGAR |
| 2024-06-11 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 96,778 @ $0.20 · Option exercise (M): 96,778 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Sale (S): 4,312 @ $5.40 | EDGAR |
| 2024-03-29 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 11,843 @ $0 · Option exercise (M): 11,843 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1878125 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →